Waisman Clinical Biomanufacturing Facility   Our primary mission is to provide GMP manufacturing services to serve researchers, clinicians and business ventures in the development of novel biological therapies for clinical trials. Toward this goal, we have a proven track record having made clinical trial material for universities, the National Institutes of Health (NIH), and both small and large companies nationally and internationally. Since opening its cGMP facility in 2001, the company has manufactured over 300 clinical grade products and has earned a reputation for working closely with clients for cost effective and timely manufacture of quality products. Our mission is to meet these high standards with each product campaign.